Related Experiment Video
Updated: Aug 18, 2026

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
Published on: December 2, 2014
Trends and treatment of heart failure developing after acute myocardial infarction
W H Wilson Tang1, Gary S Francis
1Kaufman Center for Heart Failure, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. tangne@ccf.org
Insights
Following acute myocardial infarction, heart failure remains common and increases mortality risk. Aggressive medical strategies are crucial for preventing left ventricular remodeling, saving lives, and reducing disability.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Acute myocardial infarction (AMI) frequently leads to heart failure and left ventricular systolic dysfunction.
- Despite diagnostic and therapeutic advancements, post-AMI cardiac dysfunction poses a significant mortality risk.
Purpose of the Study:
- To discuss the persistent challenge of heart failure post-AMI.
- To highlight the role of medical management in preventing adverse left ventricular remodeling.
Main Methods:
- Review of current clinical trial data and therapeutic strategies.
- Analysis of polypharmacy in patients with post-AMI cardiac dysfunction.
Main Results:
- Eplerenone and carvedilol data add complexity to treatment regimens.
- Aggressive medical strategies are vital for mitigating mortality and disability.
Conclusions:
- Preventing or reversing left ventricular remodeling post-AMI is paramount.
- Effective polypharmacy management is essential for improving outcomes in high-risk patients.
Abstract:
The development of heart failure and/or left ventricular systolic dysfunction following acute myocardial infarction remains prevalent despite improvements in the diagnosis and management over the past decades. Although transient in some cases, the majority of these patients continue to carry a substantially higher mortality risk. New data on the benefits of eplerenone and carvedilol from large clinical trials have added to the complexity of polypharmacy in this patient subgroup, although aggressive medical strategies to prevent or reverse infarct-related left ventricular remodeling remains the most effective method to save lives and prevent disabilities.
More Related Videos
Related Concept Videos
Heart Failure I: Introduction
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure VII: Nursing Interventions
Cardiomyopathy V: Interprofessional Care

